Trade Summary

2 days ago, Atkinson Edward Morrow III, serving as EVP, Chief Technical Ops. Offi at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 668 shares at $486.35 per share, for a total transaction value of $324,882.00. Following this transaction, Atkinson Edward Morrow III now holds 18,432 shares of VRTX.

This sale represents a 3.00% decrease in Atkinson Edward Morrow III's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.